Table 3.
Electronically Monitored Adherence Data
| HIV and HTN Cohort (n=102) | HIV and CKD Cohort (n=20) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adherence Measure, Median (IQR) |
HIV med |
HTN med |
Correlation Coefficient |
p-value | Z score | p-value | HIV med | CKD med | Correlation Coefficient |
p-value | Z score | p- value |
| Taking Adherence |
97.1 (11.8) |
97.1 (15.7) |
0.80 | <0.01 | −1.2 | 0.22 | 97.9 (17.3) | 96.4 (8.6) | 0.90 | < 0.01 | −1.2 | 0.23 |
| Dosing Adherence |
92.9 (19.0) |
92.9 (20.0) |
0.81 | <0.01 | −1.5 | 0.15 | 92.9 (32.2) | 92.9 (26.1) |
0.88 | < 0.01 | −0.1 | 0.94 |
| Timing Adherence |
78.3 (40.7) |
68.1 (40.7) |
0.84 | < 0.01 | −2.6 | 0.01 | 87.7 (33.3) | 86.3 (50.9) |
0.83 | < 0.01 | −0.1 | 0.91 |
| Therapeutic Coverage |
97.2 (9.7) |
95.8 (11.9) |
0.82 | < 0.01 | −1.3 | 0.18 | 98.0 (9.0) | 97.4 (6.0) | 0.85 | < 0.01 | −1.0 | 0.30 |
IQR = Interquartile Range; HTN = hypertension; CKD = chronic kidney disease